BCIQ Profiles

Company Profile ReportTarget Profile Report
0819 Abogen series C
BioCentury & Getty Images


China’s Abogen advancing mRNA vaccine for COVID-19, pipeline with $700M series C

Record-setting round, crossover investors and new CFO could position Abogen for a listing

A record-setting venture round backed by crossover investors and the addition of Chelsea Zhang as CFO could position Suzhou company for a near-term public listing.

Aug 19, 2021 | 11:56 PM GMT

The $700 million series C funding for mRNA

Read the full 696 word article

How to gain access

Continue reading with a
two-week free trial.